These infants are designated as CF transmembrane conductance regulator-related metabolic syndrome (CRMS) in the US and CF screen-positive, inconclusive diagnosis (CFSPID) in Europe. Here, CFTR is linked to CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis.